Provided by Tiger Trade Technology Pte. Ltd.

Corbus Pharmaceuticals

5.44
+0.17003.23%
Volume:355.62K
Turnover:1.91M
Market Cap:105.22M
PE:-0.89
High:5.50
Open:5.25
Low:5.17
Close:5.27
52wk High:20.56
52wk Low:5.13
Shares:19.34M
Float Shares:13.25M
Volume Ratio:0.53
T/O Rate:2.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.0889
EPS(LYR):-5.9000
ROE:-95.58%
ROA:-53.00%
PB:1.03
PE(LYR):-0.92

Loading ...

Corbus reports 42.9% response rate for CRB-701 in Phase 1/2 second-line oropharyngeal cancer study

Reuters
·
May 26

Corbus Pharmaceuticals Reports Updated Crb-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers

THOMSON REUTERS
·
May 26

Corbus Pharmaceuticals Holdings Inc - Crb-701 Generally Safe and Well Tolerated With Discontinuation Rates Below 3%

THOMSON REUTERS
·
May 26

Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers

GlobeNewswire
·
May 26

U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy

Reuters
·
May 26

Corbus Pharmaceuticals Is Maintained at Outperform by Mizuho

Dow Jones
·
May 22

Mizuho Adjusts Price Target on Corbus Pharmaceuticals to $44 From $40, Maintains Outperform Rating

MT Newswires Live
·
May 22

U.S. RESEARCH ROUNDUP-Jazz Pharmaceuticals, Target, Workday

Reuters
·
May 22

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 22

Corbus Pharma director Brent Pfeiffenberger files initial beneficial ownership statement

Reuters
·
May 22

Corbus Pharmaceuticals Appoints First Chief Business Officer

TIPRANKS
·
May 21

Corbus Pharma names Nishant Saxena chief business officer

Reuters
·
May 21

Corbus Pharmaceuticals Holdings Inc - to Initiate Registrational Study for Crb-701 in Second-Line Hnscc This Summer

THOMSON REUTERS
·
May 21

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 Asco Crb-701 Data Conference Call

THOMSON REUTERS
·
May 21

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

GlobeNewswire
·
May 21

Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 21

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
May 20

Corbus Pharmaceuticals Holdings Inc. Stock Falls 9.8%, Underperforms Peers

Dow Jones
·
May 19

Corbus Pharmaceuticals (CRBP) Receives a Buy from LifeSci Capital

TIPRANKS
·
May 16

Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 15